Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             136 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author Index 2013
 80 S1 p. S57-S62
6 p.
 artikel
2 14 CIRCULATING DNA IN LUNG CANCER: EPIGENETIC MARKERS FOR DIAGNOSTICS AND POST-TREATMENT FOLLOW-UP Ponomaryova, A.
 2013
 80 S1 p. S5-S6
2 p.
 artikel
3 Drug Index 2013
 80 S1 p. S67-
1 p.
 artikel
4 EMCTO 2013 Organisation 2013
 80 S1 p. vii-
1 p.
 artikel
5 EMCTO 2013 Scientific Committee 2013
 80 S1 p. vii-
1 p.
 artikel
6 European Respiratory Society (ERS) 2013
 80 S1 p. vi-
1 p.
 artikel
7 European Society for Medical Oncology (ESMO) 2013
 80 S1 p. iv-
1 p.
 artikel
8 European Society for Therapeutic Radiology and Oncology (ESTRO) 2013
 80 S1 p. iv-v
nvt p.
 artikel
9 European Society of Thoracic Surgeons (ESTS) 2013
 80 S1 p. v-
1 p.
 artikel
10 European Thoracic Oncology Platform (ETOP) 2013
 80 S1 p. vi-
1 p.
 artikel
11 27 EXPRESSION OF NOTCH-1 IN EGFR-TKI ACQUIRED RESISTANT LUNG ADENOCARCINOMA Xie, M.
 2013
 80 S1 p. S12-
1 p.
 artikel
12 Keyword Index 2013
 80 S1 p. S63-S65
3 p.
 artikel
13 67O ARE FIRST-LINE PLATINUM-BASED (PT) REGIMENS IMPROVING SURVIVAL IN COMPARISON WITH NON-PLATINUM (NPT) CHEMOTHERAPY (CT) IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)? A META-ANALYSIS (MA) OF RANDOMISED TRIALS Berghmans, T.
 2013
 80 S1 p. S31-
1 p.
 artikel
14 68O EFFICACY, SAFETY AND TOLERABILITY RESULTS FROM A PHASE IV, OPEN-LABEL, SINGLE ARM STUDY OF 1ST-LINE GEFITINIB IN CAUCASIAN PATIENTS (PTS) WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC) Douillard, J.
 2013
 80 S1 p. S31-
1 p.
 artikel
15 66O EGFR MUTATED PATIENTS (PTS): DIFFERENT PATTERN AND OUTCOME OF METASTATIC BONE DISEASE (MBD) AND BRAIN METASTASIS (BM)? Hendriks, L.
 2013
 80 S1 p. S30-S31
2 p.
 artikel
16 37O 18-F FDG PET TOTAL GLYCOLYTIC VOLUME IN THYMIC EPITHELIAL NEOPLASMS EVALUATION: AN EASILY REPRODUCIBLE IMAGE BIOMARKER Bertolaccini, L.
 2013
 80 S1 p. S16-S17
2 p.
 artikel
17 65O HER2 IN NON-SMALL CELL LUNG CARCINOMAS Gatalica, Z.
 2013
 80 S1 p. S30-
1 p.
 artikel
18 49O LUNG TRANSPLANTATION IN EARLY STAGE CARCINOMA OF THE EXPLANTED LUNG – IS IT A CURE FOR THE CANCER? Klikovits, T.
 2013
 80 S1 p. S22-
1 p.
 artikel
19 69O MOLECULAR FOLLOW UP OF AN ITALIAN COHORT OF EGFR MUTATED PATIENTS PROGRESSING AFTER TREATMENT WITH ORAL TYROSINE KINASE INHIBITORS Gori, B.
 2013
 80 S1 p. S32-
1 p.
 artikel
20 36O 99MTC-ETARFOLATIDE (EC20) IMAGING TO IDENTIFY NSCLC PATIENTS LIKELY TO BENEFIT FROM VINTAFOLIDE (EC145) TREATMENT Harb, W.A.
 2013
 80 S1 p. S16-
1 p.
 artikel
21 56O OUTCOMES OF CONCURRENT CHEMO-RADIOTHERAPY FOR LARGE-VOLUME STAGE III NSCLC Dahele, M.
 2013
 80 S1 p. S26-
1 p.
 artikel
22 50O PREDICTORS FOR RADIATION PNEUMONITIS AFTER SABR FOR HIGH-RISK LUNG TUMORS Bongers, E.M.
 2013
 80 S1 p. S23-
1 p.
 artikel
23 22O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSIS Kuiper, J.
 2013
 80 S1 p. S10-
1 p.
 artikel
24 23O SERUM MICRORNA AS A DIAGNOSTIC TEST FOR EARLY LUNG CANCER Veronesi, G.
 2013
 80 S1 p. S10-S11
2 p.
 artikel
25 95O SURGICAL TREATMENT OF 549 PATIENTS WITH LUNG METASTASES FROM COLORECTAL CARCINOMA. INITIAL RESULTS OF A PROSPECTIVE SPANISH STUDY Molins, L.
 2013
 80 S1 p. S41-
1 p.
 artikel
26 1O THE LUNGPATH STUDY – OPTIMISING THE PATHOLOGICAL DIAGNOSIS OF LUNG CANCER Cane, P.
 2013
 80 S1 p. S1-
1 p.
 artikel
27 48O TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MLPC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) Griffioen, G.H.M.J.
 2013
 80 S1 p. S22-
1 p.
 artikel
28 15O VOLUMETRIC COMPUTER TOMOGRAPHY SCREENING FOR LUNG CANCER: THREE ROUNDS OF THE NELSON TRIAL Horeweg, N.
 2013
 80 S1 p. S7-
1 p.
 artikel
29 93P A COMPARATIVE STUDY OF DOCETAXEL PLUS CISPLATIN COMPARED WITH GEMCITABINE PLUS CISPLATIN IN TREATING ADVANCED NON-SMALL CELL LUNG CANCER ElHindawy, E.
 2013
 80 S1 p. S40-
1 p.
 artikel
30 31P ALK ASSESSMENT WITH FISH, IHC AND AQUA IN GREEK NSCLC PATIENTS Kotoula, V.
 2013
 80 S1 p. S13-
1 p.
 artikel
31 54P A PHASE I/II TRIAL OF CONCURRENT CHEMO-RADIATION WITH DOSE-ESCALATED RADIOTHERAPY IN PATIENTS WITH STAGE II OR STAGE III NON-SMALL CELL LUNG CANCER Landau, D.B.
 2013
 80 S1 p. S24-
1 p.
 artikel
32 60P A RANDOMIZED TRIAL COMPARING CONVENTIONAL FRACTIONATION VERSUS ACCELERATED HYPERFRACTIONATION WITH THREE DIMENSIONAL CONFORMAL RADIOTHERAPY (3D-CRT) AND CONCURRENT CHEMOTHERAPY IN UNRESECTABLE NON SMALL CELL LUNG CANCER Sapkota, S.
 2013
 80 S1 p. S27-
1 p.
 artikel
33 92P ARCHER 1050: PHASE III RANDOMIZED STUDY OF 1ST-LINE DACOMITINIB (D) VS GEFITINIB (G) FOR ADVANCED (ADV) NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS (PTS) WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION(S) Mok, T.S.K.
 2013
 80 S1 p. S39-S40
2 p.
 artikel
34 18P ‘ASK THE EXPERT’ PROMOTING EARLY DIAGNOSIS OF LUNG CANCER Thomas, R.
 2013
 80 S1 p. S8-
1 p.
 artikel
35 105P A UNIQUE CASE OF SALIVARY PLEOMORPHIC ADENOMA CHANGING INTO HYALINIZING CLEAR CELL CARCINOMA WITH PULMONARY METASTASIS Raveglia, F.
 2013
 80 S1 p. S44-S45
2 p.
 artikel
36 78P AVAILABILITY OF EGFR MUTATION STATUS AT FIRST ONCOLOGY CONSULTATION FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS. A PILOT EXPERIENCE FROM THE CHRISTIE Evans, M.
 2013
 80 S1 p. S35-
1 p.
 artikel
37 20P A 10 YEARS SURVEY OF LUNG CANCER IN SHAHID RAJAI RADIOTHERAPY CENTER IN NORTH OF IRAN Moslemi, D.
 2013
 80 S1 p. S8-S9
2 p.
 artikel
38 46P BASAL (PRE-TREATMENT) PET SCAN [MAXIMUM STANDARDIZED UPTAKE VALUES (SUVMAX)] AS A PROGNOSTIC FACTOR IN SMALL CELL LUNG CANCER PATIENTS WITH EXTENDED DISEASE Aix, S. Ponce
 2013
 80 S1 p. S20-
1 p.
 artikel
39 85P BENEFIT OF MAINTENANCE THERAPY IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) ACCORDING TO RESPONSE TO FIRST LINE THERAPY Garde, J.
 2013
 80 S1 p. S37-S38
2 p.
 artikel
40 7P BONE MARROW MESENCHYMAL STEM CELLS DELETERIOUSLY AFFECT LUNG CANCER CELL LINES Gottfried, M.
 2013
 80 S1 p. S3-
1 p.
 artikel
41 34P BRONCHIAL-PULMONARY CARCINOMA: PET SCAN SUVS AND MITOCHONDRIAL DNA COPY NUMBER CORRELATE WITH HISTOLOGICAL SUB-TYPING Carvalho, L.
 2013
 80 S1 p. S14-
1 p.
 artikel
42 6P CHEMOTHERAPY-ENFORCED EXPRESSION OF CANCER STEM CELL MARKERS IN A SERIES OF THREE SCLC CELL LINES OBTAINED DURING CLINICAL TREATMENT Hamilton, G.
 2013
 80 S1 p. S3-
1 p.
 artikel
43 81P CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER Bensaou, M. Gamaz
 2013
 80 S1 p. S36-
1 p.
 artikel
44 63P CISPLATIN–DOCETAXEL FOLLOWED BY WEEKLY DOCETAXEL IN ASSOCIATION WITH THORACIC RADIOTHERAPY IN LOCALLY ADVANCED NSCLC: PRELIMINARY RESULTS OF A PHASE II TRIAL Scotti, V.
 2013
 80 S1 p. S28-S29
2 p.
 artikel
45 17P CLINICAL AND PROGNOSTIC IMPLICATIONS DUE TO DELETIONS IN THE P53 GENE IN NON SMALL CELL LUNG CANCER PATIENTS Mir, A.R.
 2013
 80 S1 p. S7-S8
2 p.
 artikel
46 77P CLINICAL OUTCOMES OF CONTINUING EGFR RECEPTOR TYROSINE KINASE INHIBITORS AFTER RECIST PROGRESSION OF BONE METASTASIS IN EGFR-MUTANT NSCLC Hong, S.H.
 2013
 80 S1 p. S35-
1 p.
 artikel
47 4P CLINICO-PATHOLOGICAL CHARACTERISTICS OF PATIENTS WITH LUNG ADENOCARCINOMA HARBOURING MUTATIONS IN THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) GENE IN THE SERBIAN POPULATION Zaric, B.
 2013
 80 S1 p. S2-
1 p.
 artikel
48 21P CLINICOPATHOLOGICAL FEATURES OF ELDERLY PATIENTS WITH NSCLC; SINGLE INSTITUTIONAL EXPERIENCE FROM EGYPT Shahin, M.
 2013
 80 S1 p. S9-
1 p.
 artikel
49 82P COMBINED MODALITY THERAPY OF ADVANCED NON-SMALL-CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCE Resuli, B.
 2013
 80 S1 p. S36-S37
2 p.
 artikel
50 55P COMBINED TREATMENT OF OPERABLE LUNG CANCER WITH DIFFERENT TYPES OF FRACTIONATION POSTOPERATIVE RADIOTHERAPY Ragulin, Y.
 2013
 80 S1 p. S25-
1 p.
 artikel
51 43P CONDITIONAL PROBABILITY OF SURVIVAL IN SMALL CELL LUNG CANCER Naidoo, J.
 2013
 80 S1 p. S19-
1 p.
 artikel
52 122PD AGE SPECIFIC RISK ASSESSMENT IN SENIOR LUNG CANCER PATIENTS Lukavetskyy, N.
 2013
 80 S1 p. S54-
1 p.
 artikel
53 25PD CIRCULATING MICRO-RNA PROFILING IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON SMALL-CELL LUNG CANCER RECEIVING BEVACIZUMAB/ERLOTINIB FIRST-LINE TREATMENT FOLLOWED BY PLATINUM-BASED CHEMOTHERAPY AT DISEASE PROGRESSION (SAKK 19/05) Joerger, M.
 2013
 80 S1 p. S11-
1 p.
 artikel
54 38PD CURRENT ROLE OF VATS IN THE DIAGNOSIS OF A MEDIASTINAL LYMPHADENOPATHY OF UNKNOWN ETIOLOGY Lo Faso, F.
 2013
 80 S1 p. S17-
1 p.
 artikel
55 70PD EFFECT OF ENOBOSARM, A SELECTIVE ANDROGEN RECEPTOR MODULATOR, IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH MUSCLE WASTING IN A PHASE IIB TRIAL Croot, C.C.
 2013
 80 S1 p. S32-
1 p.
 artikel
56 26PD FORETINIB (GSK1363089), A MULTIKINASE INHIBITOR OF MET AND VEGFS, OVERCOMES RESISTANCE TO BEVACIZUMAB IN AN IN VIVO MODEL OF ACQUIRED BEVACIZUMAB RESISTANCE Xie, M.
 2013
 80 S1 p. S11-S12
2 p.
 artikel
57 30P DIFFERENTIAL MICRORNA EXPRESSION AND TARGET GENES BETWEEN LUNG CANCER AND NORMAL TISSUE Lee, H.
 2013
 80 S1 p. S13-
1 p.
 artikel
58 109P DIFFICULTIES OF DIAGNOSIS, RESULTS OF TREATMENT OF SOLITARY AND DIFFUSIVE FORMS OF MESOTHELIOMA Voloshyn, Y.
 2013
 80 S1 p. S47-
1 p.
 artikel
59 72PD IMPACT OF EGFR STATUS ON THE PRESENCE OF LIVER METASTASES (LM) FROM NON-SMALL CELL LUNG CANCER (NSCLC) AND SURVIVAL IMPLICATIONS Alvarez, E. Castañón
 2013
 80 S1 p. S33-
1 p.
 artikel
60 2PD ISOLATION AND CHARACTERIZATION OF CIRCULATING TUMOR CELLS IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE LUNG Bozzetti, C.
 2013
 80 S1 p. S1-
1 p.
 artikel
61 24PD METABOLOMIC PROFILE OF LUNG CANCER PATIENTS Puchades-Carrasco, L.
 2013
 80 S1 p. S11-
1 p.
 artikel
62 57PD NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED NON SMALL CELL LUNG CANCER Toker, A.
 2013
 80 S1 p. S26-S27
2 p.
 artikel
63 127P DOSE PERTURBATION CAUSED BY GOLD FIDUCIAL CT ARTIFACTS DURING PROTON LUNG RADIATION THERAPY Gueorguiev, G.
 2013
 80 S1 p. S55-S56
2 p.
 artikel
64 96PD PATTERN AND SURVIVAL OF LUNG METASTASIS IN YOUNG BREAST CANCER PATIENTS: A SINGLE CENTRE EXPERIENCE Gogia, A.
 2013
 80 S1 p. S41-
1 p.
 artikel
65 59PD PRE- AND INTRAOPERATIVE PHOTODYNAMIC THERAPY IN LOCALLY ADVANCED CENTRAL NSCLC Akopov, A.
 2013
 80 S1 p. S27-
1 p.
 artikel
66 123PD PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS WITH LUNG CANCER AND BRAIN METASTASES Jochymek, B.D.
 2013
 80 S1 p. S54-
1 p.
 artikel
67 71PD REVERSIBLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASES INIHIBITORS (REGFR-TKIS), ERLOTINIB OR GEFITINIB, COMPARED TO CHEMOTHERAPY (CHT) IN PREVIOUSLY TREATED METASTATIC NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS): A META-ANALYSIS Pochesci, A.
 2013
 80 S1 p. S32-S33
2 p.
 artikel
68 40PD SMALL CELL LUNG CANCER AND HYPONATREMIA: INTERIM RESULTS FROM A PROSPECTIVE, OBSERVATIONAL, GLOBAL REGISTRY Makin, A.
 2013
 80 S1 p. S18-
1 p.
 artikel
69 58PD VATS LOBECTOMY AFTER INDUCTION THERAPY FOR LUNG CANCER: A SAFE AND EFFECTIVE METHOD Wu, Y.C.
 2013
 80 S1 p. S27-
1 p.
 artikel
70 112P EARLY DIAGNOSTIC OF THE PLEURAL CANCER OF PATIENTS WITH TUBERCULOSIS ETIOLOGICAL PLEURITIS Aliyev, K.
 2013
 80 S1 p. S48-
1 p.
 artikel
71 111P EFFECTIVENESS OF MESOTHELIN FAMILY PROTEINS AND OSTEOPONTIN FOR MALIGNANT MESOTHELIOMA Pantazopoulos, I.
 2013
 80 S1 p. S47-S48
2 p.
 artikel
72 5P EGFR GENE MUTATION IN ADVANCED NON-SMALL CELL LUNG CANCER Mehmood, T.
 2013
 80 S1 p. S2-
1 p.
 artikel
73 79P ERLOTINIB EFFICACY IN PRETREATED EGFR WILD-TYPE CAUCASIAN PATIENTS: A MULTIVARIATE ANALYSIS IDENTIFIYNG FAVOURABLE PROGNOSTIC/PREDICTIVE FACTORS Gori, B.
 2013
 80 S1 p. S35-S36
2 p.
 artikel
74 90P ERLOTINIB VS CHEMOTHERAPY AS SECOND LINE THERAPY FOR PATIENTS WITH ADVANCED EGFRWT NON SMALL CELL LUNG CANCER. A SINGLE INSTITUTION EXPERIENCE Garde, J.
 2013
 80 S1 p. S39-
1 p.
 artikel
75 3P FLUORESCENCE IN SITU HYBRIDIZATION (FISH) FOR DETECTION OF ALK REARRANGEMENTS VIA THINPREP CYTOLOGY PREPARATIONS IN NON SMALL CELL LUNG CARCINOMA (NSCLC) Tubbs, R.
 2013
 80 S1 p. S2-
1 p.
 artikel
76 91P GEFITINIB PLUS ZOLEDRONIC ACID ROLE IN BONE METASTASES FROM EGFR MUT+VE NSCLC PATIENTS Del Signore, E.
 2013
 80 S1 p. S39-
1 p.
 artikel
77 33P GENE EXPRESSION PROFILE OF CLASSICAL (CD14++CD16−) MONOCYTES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IS ALTERED BY CHEMOTHERAPY McCarthy, F.
 2013
 80 S1 p. S14-
1 p.
 artikel
78 73P GENE MUTATIONS IN SQUAMOUS-CELL NSCLC: INSIGNIFICANCE OF EGFR, KRAS AND PIK3CA MUTATIONS IN PREDICTION OF EGFR-TKI TREATMENT EFFICACY Fiala, O.
 2013
 80 S1 p. S33-
1 p.
 artikel
79 107P IMPACT OF PREINTERVENTIONAL PLASMA FIBRINOGEN AS A PROGNOSTIC MARKER IN MALIGNANT PLEURAL MESOTHELIOMA Klikovits, T.
 2013
 80 S1 p. S46-
1 p.
 artikel
80 62P IMPACT OF THE USE OF SIMULATION 18-FDG PET/CT ON TARGET VOLUMES AND DOSIMETRIC PARAMETERS IN THE TREATMENT OF LOCALLY ADVANCED NSCLC (NON SMALL CELL LUNG CANCER): PRELIMINARY RESULTS ON 35 PATIENTS Furfaro, I.F.
 2013
 80 S1 p. S28-
1 p.
 artikel
81 120P INTERVENTIONAL FLEXIBLE BRONCHOSCOPIC MANAGEMENT IN ENDOBRONCHIAL OBSTRUCTION: A SINGLE-CENTER EXPERIENCE Ahn, J.H.
 2013
 80 S1 p. S52-
1 p.
 artikel
82 44P INVESTIGATING GENDER AS PROGNOSTIC FACTOR IN PATIENTS WITH LIMITED DISEASE SCLC TREATED WITH CHEMORADIOTHERAPY Manapov, F.
 2013
 80 S1 p. S19-S20
2 p.
 artikel
83 41P IS THERE ANY ROLE FOR CIRCULATING TUMOR CELLS IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)? Olmedo, E.
 2013
 80 S1 p. S18-S19
2 p.
 artikel
84 52P LIMITED RESECTION PROVIDES WORSE PROGNOSIS IN SOLID TYPE CLINICAL STAGE IA NON SMALL CELL LUNG CANCER Jeon, H.W.
 2013
 80 S1 p. S23-S24
2 p.
 artikel
85 98P LONG TERM FOLLOW UP OF PATIENTS TREATED WITH CYBERKNIFE STEREOTACTIC BODY RADIOTHERAPY FOR OLIGOMETASTATIC LUNG CANCER Beltramo, G.
 2013
 80 S1 p. S42-
1 p.
 artikel
86 19P LUNG CANCER AS A SECOND MALIGNANCY AFTER INITIAL TREATMENT OF PRIMARY NON LUNG CANCER – A SINGLE INSTITUTION EXPERIENCE Nikolic, N.
 2013
 80 S1 p. S8-
1 p.
 artikel
87 102P LUNG METASTASECTOMY IN CRC PATIENTS: A PORTUGUESE SINGLE-INSTITUTION EXPERIENCE Miguel, I.
 2013
 80 S1 p. S43-S44
2 p.
 artikel
88 84P MAINTENANCE LOW-DOSE GEMCITABINE VERSUS BEST SUPPORTIVE CARE IN ADVANCED AND METASTATIC NON-SMALL CELL LUNG CANCER: RANDOMIZED PHASE III TRIAL Nagy, A.A.
 2013
 80 S1 p. S37-
1 p.
 artikel
89 110P MALIGNANT PLEURAL MESOTHELIOMA: CLINICOPATHOLOGIC AND SURVIVAL CHARACTERISTICS IN A CONSECUTIVE SERIES OF 40 PATIENTS Bagheri, R.
 2013
 80 S1 p. S47-
1 p.
 artikel
90 80P MANAGEMENT OF ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: A SINGLE CENTRE EXPERIENCE Früh, M.
 2013
 80 S1 p. S36-
1 p.
 artikel
91 97P MANAGEMENT OF LUNG METASTASES FROM COLORECTAL CANCER: VIDEO-ASSISTED THORACOSCOPIC SURGERY VERSUS THORACOTOMY – A CASE-MATCHED STUDY Chao, Y.K.
 2013
 80 S1 p. S42-
1 p.
 artikel
92 13P NON SQUAMOUS NSCLC IS MORE PLATINUM SENSITITVE THAN SQUAMOUS NSCLC Fouad, E.
 2013
 80 S1 p. S5-
1 p.
 artikel
93 115P ORAL ETOPOSIDE IN PRETREATED ADVANCED THYMOMA AND THYMIC CARCINOMA. A FRENCH EXPERIENCE Boutros, C.
 2013
 80 S1 p. S49-S50
2 p.
 artikel
94 10P OVEREXPRESSION OF REGULATOR OF G-PROTEIN SIGNALING 5 REDUCES THE SURVIVAL RATE AND ENHANCES THE RADIATION RESPONSE OF HUMAN LUNG CANCER CELLS Xu, Z.
 2013
 80 S1 p. S4-
1 p.
 artikel
95 8P P53 AB-1 (CLONE PAB 240) MAY BE USED IN BRONCHIAL-PULMONARY CARCINOMAS TO SCREEN MUTATED PROTEIN Carvalho, L.
 2013
 80 S1 p. S3-
1 p.
 artikel
96 125P PHARMACOKINETICS STUDY OF BRONCHIAL ARTERY INFUSION CHEMOTHERAPY IN DOG LUNG ON THE BASIS OF MICRODIALYSIS TECHNIQUE An, X.
 2013
 80 S1 p. S55-
1 p.
 artikel
97 83P PHYSICAL EXERCISE TRAINING IN PATIENTS WITH NON SMALL CELL LUNG CANCER (NSCLC): RESULTS OF A FEASIBILITY STUDY Wiskemann, J.
 2013
 80 S1 p. S37-
1 p.
 artikel
98 61P PHYSICO-BIOLOGICAL TREATMENT PLAN OPTIMIZATION FOR INDIVIDUALIZED DOSE ESCALATION IN ADVANCED NON-SMALL CELL LUNG CANCER RADIOTHERAPY: MAXIMALLY ACHIEVABLE TUMOR DOSE VERSUS RISK OF RADIATION PNEUMONITIS Troost, E.G.C.
 2013
 80 S1 p. S28-
1 p.
 artikel
99 32P PIGMENT EPITHELIUM-DERIVED FACTOR ENHANCES TUMOR RESPONSE TO RADIATION BY NORMALIZING VASCULATURE IN A XENOGRAFTED MODEL OF LUNG CANCER Xu, Z.
 2013
 80 S1 p. S13-S14
2 p.
 artikel
100 101P PREOPERATIVE CEFAZOLIN PROPHYLAXIS PREVENTS SURGICAL SITE INFECTIONS IN PATIENTS UNDERGOING OPEN AND THORACOSCOPIC METASTASECTOMY FOR LUNG METASTASES. A CASE–CONTROL STUDY Lumachi, F.
 2013
 80 S1 p. S43-
1 p.
 artikel
101 94P PREVALENCE OF ACTIVATING EGFR MUTATIONS IN PATIENTS WITH ADENOCARCINOMA OF LUNG CANCER IN ALGERIAN SERIES Bensaou, M. Gamaz
 2013
 80 S1 p. S40-
1 p.
 artikel
102 118P PRIMARY PLEURAL LYMPHOMA: A CASE OF PRIMARY PLEURAL T-CELL NON-HODGKIN'S LYMPHOMA WITH EMPYEMA OF THE CHEST Hussein, H.S.
 2013
 80 S1 p. S50-S51
2 p.
 artikel
103 86P PROGNOSTIC FACTORS IN METASTATIC NON SMALL CELL LUNG CANCER: A SINGLE INSTITUTION EXPERIENCE Benbrahim, Z.
 2013
 80 S1 p. S38-
1 p.
 artikel
104 76P PROLONGED PEMETREXED TREATMENT AS EVERY 4 WEEK SCHEDULE IN NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS Kwon, J.H.
 2013
 80 S1 p. S34-
1 p.
 artikel
105 106P PROTEOMIC ANALYSIS SHOWED HEAT SHOCK 70 KDA PROTEIN AND 78 KDA GLUCOSE-REGULATED PROTEIN WERE UP-REGULATED IN HUMAN MALIGNANT PLEURAL MESOTHELIOMA CELLS Kuramitsu, Y.
 2013
 80 S1 p. S46-
1 p.
 artikel
106 99P PULMONARY METASTASECTOMY AND REPEATED METASTASECTOMY FOR SOFT TISSUE SARCOMA Bagheri, R.
 2013
 80 S1 p. S42-
1 p.
 artikel
107 75P REDUCED FOLATE CARRIER (RFC) AS A PREDICTIVE MARKER FOR RESPONSE TO PEMETREXED IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) Fernandez, C. Alvarez
 2013
 80 S1 p. S34-
1 p.
 artikel
108 74P RELATION BETWEEN CYTOCHROME P450 (CYP) POLYMORPHISMS AND BIO-AVAILABILITY AND ADVERSE EVENTS (AE) OF TYROSINE KINASE INHIBITORS (TKIS) Brouns, A.
 2013
 80 S1 p. S33-S34
2 p.
 artikel
109 9P RELATIONSHIP OF VEGF AND P16 EXPRESSION IN TUMOR AND TUMOR SURROUNDING TISSUE TO SPIROMETRY TESTS AND SURVIVAL OUTCOMES OF NON-SMALL-CELL LUNG CANCER PATIENTS Jusufovic, E.
 2013
 80 S1 p. S4-
1 p.
 artikel
110 116P RETROSPECTIVE ANALYSIS OF PATIENTS WITH THYMIC MALIGNANCIES TREATED AT THE VALL D'HEBRON UNIVERSITY HOSPITAL Martínez, P.
 2013
 80 S1 p. S50-
1 p.
 artikel
111 104P RISK FACTORS OF LUNG METASTASES FROM ADVANCED INVASIVE DUCTAL CARCINOMA OF THE BREAST Lumachi, F.
 2013
 80 S1 p. S44-
1 p.
 artikel
112 29P RNA SEQ REVEALS GENE EXPRESSION PROFILES OF NON-SMALL CELL LUNG CANCER Han, S.
 2013
 80 S1 p. S12-S13
2 p.
 artikel
113 53P ROBOTIC RADIOSURGERY FOR INOPERABLE PATIENTS WITH STAGE IA–IB NON SMALL CELL LUNG CANCER Beltramo, G.
 2013
 80 S1 p. S24-
1 p.
 artikel
114 121P ROLE OF EXERCISE FOR THE MANAGEMENT OF CANCER-RELATED FATIGUE IN LUNG CANCER: SYSTEMATIC REVIEW Paramanandam, V.S.
 2013
 80 S1 p. S52-S53
2 p.
 artikel
115 88P ROS1(+) LUNG ADENOCARCINOMA TREATED WITH CRIZOTINIB – CASE REPORT Matsouka, F.
 2013
 80 S1 p. S38-S39
2 p.
 artikel
116 113P SARCOMA OF LUNG, PLEURA Voloshyn, Y.
 2013
 80 S1 p. S49-
1 p.
 artikel
117 103P SERUM MARKERS OF BONE METABOLISM MEASUREMENT IN PATIENTS WITH BREAST CANCER AND LUNG METASTASIS Lumachi, F.
 2013
 80 S1 p. S44-
1 p.
 artikel
118 16P SIMPLE NANOPARTICLE-BASED ASSAY FOR DETECTION OF LUNG CANCER MICRORNAS BIOMARKERS Vo-Dinh, T.
 2013
 80 S1 p. S7-
1 p.
 artikel
119 45P SMALL CELL LUNG CANCER (SCLC) IN ELDERLY PATIENTS (PTS) Unk, M.
 2013
 80 S1 p. S20-
1 p.
 artikel
120 51P STEREOTACTIC BODY RADIATION THERAPY IN OCTOGENARIANS WITH EARLY STAGE LUNG CANCER Sandhu, A.P.
 2013
 80 S1 p. S23-
1 p.
 artikel
121 12P SUPEROXIDE DISMUTASE ACTIVITY AS A PREDICTIVE SIGN OF MALIGNANCY OF THE TUMOR PROCESS IN LUNG CANCER PATIENTS Ragulin, Y.
 2013
 80 S1 p. S5-
1 p.
 artikel
122 114P SURGICAL TREATMENT OF ADENOCYSTIC CANCER OF THE TRACHEA Mosina, N.V.
 2013
 80 S1 p. S49-
1 p.
 artikel
123 119P SURVIVAL ANALYSIS IN PATIENTS WITH MALIGNANT AIRWAY STENOSIS REFERRED FOR ENDOBRONCHIAL INTERVENTION AND SUBSEQUENT ANTI-CANCER TREATMENT Dudzevicius, V.
 2013
 80 S1 p. S52-
1 p.
 artikel
124 126P THE ANTI-TUMOR IMMUNE RESPONSES IN THROMBOCYTOPENIC MOUSE TUMOR MODEL Lee, S.Y.
 2013
 80 S1 p. S55-
1 p.
 artikel
125 11P THE INHIBITION OF CD26/DPP4 REDUCES LUNG TUMOUR GROWTH IN MICE Jang, J.
 2013
 80 S1 p. S4-S5
2 p.
 artikel
126 42P THE PREDICTIVE SIGNIFICANCE OF LEPTIN, ADIPONECTIN, RESISTIN AND GHRELIN SERUM LEVELS AT DIAGNOSIS OF PATIENTS WITH SMALL CELL LUNG CANCER Tourkantonis, I.
 2013
 80 S1 p. S19-
1 p.
 artikel
127 87P THE PROGNOSTIC PREDICTORS OF 2ND LINE CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER Chang, J.H.
 2013
 80 S1 p. S38-
1 p.
 artikel
128 28P THE PROGNOSTIC SIGNIFICANCE OF THE STROMAL CELL MARKER SPARC IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER Yun, H.J.
 2013
 80 S1 p. S12-
1 p.
 artikel
129 108P THE VALUE OF THE GLASGOW PROGNOSTIC SCORE IN PATIENTS UNDERGOING SURGERY FOR MALIGNANT PLEURAL MESOTHELIOMA Hoda, M.
 2013
 80 S1 p. S46-S47
2 p.
 artikel
130 100P THORACOSCOPIC OUTPATIENT WEDGE LUNG RESECTION: IS IT A SAFE AND EFFECTIVE PROCEDURE? Cafarotti, S.
 2013
 80 S1 p. S42-S43
2 p.
 artikel
131 124P THYMECTOMY BETWEEN VIDEO-ASSISTED THORACOSCOPY AND DIFFERENT OPEN SURGICAL TECHNIQUES Muhammad, M.I.A.
 2013
 80 S1 p. S54-S55
2 p.
 artikel
132 117P THYMOMA: A REVIEW OF THE CLINICAL AND PATHOLOGICAL FINDINGS IN 30 CASES Gradica, F.
 2013
 80 S1 p. S50-
1 p.
 artikel
133 47P TREATMENT OPTIONS FOR SMALL CELL LUNG CANCER: DOES LANREOTIDE REPRESENT A NEW CHOICE? Franchina, T.
 2013
 80 S1 p. S20-S21
2 p.
 artikel
134 39P USEFULNESS OF ENDOBRONCHIAL ULTRASOUND IN THE DIAGNOSIS OF PERIPHERAL PULMONARY LESIONS IN A GENERAL HOSPITAL Kokkonouzis, I.
 2013
 80 S1 p. S17-
1 p.
 artikel
135 35 ROLE OF CXCL4 CHEMOKINE IN ANGIOGENIC ACTIVITY OF NON-SMALL CELL LUNG CANCER (NSCLC) Spaks, A.
 2013
 80 S1 p. S15-
1 p.
 artikel
136 Translation research Index 2013
 80 S1 p. S68-
1 p.
 artikel
                             136 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland